170870 ⎘
Detection or diagnosis of diseases; Cardiovascular disorders Vasculitis, i.e. inflammation of blood vessels
DIAGNOSIS OF IMMUNE-MEDIATED INFLAMMATORY DISEASES USING MMP12 AS INDICATOR, AND MEDICINE FOR TREATING IMMUNE-MEDIATED INFLAMMATORY DISEASES VIA MMP12 INHIBITION
#2INFLAMMATORY DISEASE GENE PANEL
#3KAWASAKI DISEASE DETERMINATION KIT AND KAWASAKI DISEASE DETERMINATION METHOD
#4MONOCLONAL ANTIBODIES FOR DETECTING KAWASAKI DISEASE ANTIGENS
#5FAB-LINKED GLYCANS AS BIOMARKER FOR THE TRANSITION FROM A PRE DISEASE "AT-RISK-PHASE" TO RHEUMATOID ARTHRITIS, AAV OR SJÖGREN SYNDROME
#6DIAGNOSTIC METHODS FOR KAWASAKI DISEASE
#7COMPOSITIONS AND METHODS FOR REGULATING LEUKOCYTE ADHESION
#8C5aR INHIBITOR REDUCTION OF URINARY sCD163
#9KAWASAKI DISEASE DETERMINATION KIT AND KAWASAKI DISEASE DETERMINATION METHOD
#10DRUG TREATMENT AND BIOMARKER PANEL TARGETED TO DISEASES DUE TO MULTIFACTORIAL ONTOLOGY OF GLYCOCALYX DISRUPTION
#11METHODS, ARRAYS AND USES THEREOF FOR DIAGNOSING OR DETECTING AN AUTOIMMUNE DISEASE
#12KAWASAKI DISEASE ANTIBODIES IDENTIFY HEPACIVIRUS PEPTIDES
#13Methods and Compositions for the Diagnosis and Treatment of Kawasaki Disease
#14Exosome profiling for diagnosis and monitoring of vasculitis and vasculopathies including Kawasaki disease
#15Fab-linked glycans as biomarker for the transition from a pre-disease “at-risk-phase” to rheumatoid arthritis; AAV or Sjögren syndrome
#16Methods of detection and treatment for cardiovascular disease and foot wounds
#17Compositions and methods for regulating leukocyte adhesion
#18METHOD FOR DIAGNOSING AN INFLAMMATORY DISORDER
#19Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients
#20METHOD, KIT AND TEST STRIP FOR DETECTING KAWASAKI DISEASE
#21Diagnosis and treatment of Kawasaki disease
#22METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF KAWASAKI DISEASE
#23Methods of Using Interleukin-10 for Treating Diseases and Disorders
#24METHODS FOR DIAGNOSIS OF KAWASAKI DISEASE
#25Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
#26Method for the diagnosis of rosacea
#27Diagnostic markers and therapeutic targets of kawasaki disease
#28Cell division marker
#29Methods and means for diagnosing vasculitis
#30Testing method and testing reagent for angiitis
#31Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients
#32METHOD FOR DIAGNOSING VASCULITIS
#33Naphthalene-based inhibitors of anti-apoptotic proteins
#34Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#35METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
#36METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF VASCULAR INFLAMMATORY DISORDERS OR ENDOTHELIAL CELL DISORDERS
#37METHOD FOR THE IN VITRO DIAGNOSIS OF AN AUTOIMMUNE RESPONSE ASSOCIATED WITH THE EXISTENCE OF AN ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES-ASSOCIATED VASCULITIS BY DETECTION OF ANTIBODIES DIRECTED AGAINST THE PENTRAXIN 3 ANTIGEN
#38Protein Biomarkers and Methods for Diagnosing Kawasaki Disease
#39Use application of sugar chain-recognizing receptor
#40Cell division marker
#41Diagnostic and therapeutic tools for diseases altering vascular function
#42Naphthalene-based inhibitors of anti-apoptotic proteins
#43METHODS FOR TREATMENT AND/OR PREVENTION OF A DISEASE ASSOCIATED WITH VASCULAR LEAK
#44BIOMARKERS FOR CARDIOVASCULAR SIDE-EFFECTS INDUCED BY COX-2 INHIBITORY COMPOUNDS
#45Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
#46Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
#47METHODS OF SCREENING FOR COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY
#48Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
#49Cell division marker
#50OPIATE, CANNABINOID, AND ESTROGEN RECEPTORS
#51Methods for detecting vasculopathies and tumors